Isavuconazole for the Prevention of COVID-19-associated Pulmonary Aspergillosis
Condition(s):Severe Acute Respiratory Syndrome Coronavirus 2; Aspergillosis InvasiveLast Updated:November 25, 2022Terminated
Hide Studies Not Open or Pending
Condition(s):Severe Acute Respiratory Syndrome Coronavirus 2; Aspergillosis InvasiveLast Updated:November 25, 2022Terminated
Condition(s):Pharmacokinetics of Isavuconazole; Pharmacokinetics of Ethinyl Estradiol and Norethindrone; Healthy VolunteersLast Updated:July 16, 2012Completed
Condition(s):HealthyLast Updated:December 19, 2011Completed
Condition(s):Aspergillosis; Invasive Fungal InfectionsLast Updated:January 2, 2018Completed
Condition(s):Pharmacokinetics of Isavuconazole; Healthy Volunteers; Renal ImpairedLast Updated:September 1, 2015Completed
Condition(s):Pharmacokinetics of 14C-labeled Isavuconazole; Healthy SubjectsLast Updated:March 19, 2013Completed
Condition(s):Pharmacokinetics of Isavuconazole; Healthy VolunteersLast Updated:July 9, 2012Completed
Condition(s):Pharmacokinetics of BAL4815; Pharmacokinetics of BAL8728; Healthy VolunteersLast Updated:February 1, 2013Completed
Condition(s):Pharmacokinetics of Isavuconazole; Pharmacokinetics of Dextromethorphan; Healthy Adult VolunteersLast Updated:February 23, 2015Completed
Condition(s):Healthy Subjects; Pharmacokinetics of Isavuconazole; Pharmacokinetics of Plasma Mycophenolic Acid (MPA); Pharmacokinetics of Plasma Phenolic Glucuronide of MPA (MPAG)Last Updated:October 22, 2012Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.